Physician profile
Joyce George
NPI 1669768842
$4,050.69
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,527 · 2020: $907 · 2021: $802 · 2022: $467 · 2023: $222 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $442.91 | 2019-2021 | |
| Abbott Laboratories | $436.09 | 2019-2023 | Freestyle Libre 2 |
| Lilly USA, LLC | $398.15 | 2019-2023 | Jardiance |
| Amgen INC. | $394.52 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $358.01 | 2019-2022 | |
| Insulet Corporation | $245.29 | 2019-2021 | |
| Radius Health, INC. | $204.62 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $180.10 | 2019 | |
| Merck Sharp & Dohme LLC | $142.25 | 2019-2021 | |
| Horizon Therapeutics Plc | $138.20 | 2021-2023 | Krystexxa |
| Abbvie INC. | $134.43 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.55 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.56 | 2024 | |
| Sanofi-Aventis U.S. LLC | $116.15 | 2019-2021 | |
| Medtronic Minimed, INC. | $89.30 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $82.84 | 2019-2021 | |
| Medtronic, INC. | $73.74 | 2021 | |
| Dexcom, INC. | $57.45 | 2019-2021 | |
| Mannkind Corporation | $56.16 | 2019 | |
| Valeritas, INC. | $53.65 | 2019 | |
| Shire North American Group INC | $45.39 | 2019 | |
| Xeris Pharmaceuticals, INC. | $34.24 | 2020-2021 | |
| Tandem Diabetes Care, INC. | $19.97 | 2019 | |
| Pfizer INC. | $17.31 | 2019 | |
| Esperion Therapeutics, INC. | $17.12 | 2021 | |
| Amarin Pharma, INC. | $16.76 | 2020 | |
| Ermi LLC | $16.35 | 2020 | |
| Ibsa Pharma INC. | $13.85 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.